Pipothiazine palmitate in the long-term treatment of schizophrenia.
Fifty patients suffering from active schizophrenic episodes were treated with electroplexy and thioproperazine for 3 weeks. Pipothiazine palmitate was then given parenterally at a dose of 100 mg at 4-week intervals over a period of 3 years. It seemed to be effective in maintaining remissions in forty-eight patients.
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008297:Male; D010640:Phenothiazines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy*
D014150:Antipsychotic Agents; D010640:Phenothiazines